CLINICAL_TRIALS ClinicalTrials.gov record update

Reduced Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Randomised, Multi-Center, Phase III Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05674539
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:52.682626+00:00
Published At: 2025-02-10T00:00:00+00:00
Record Updated At: 2025-02-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Myeloid Leukemia, Adult", "Myelodysplastic Syndrome(MDS)", "Allogeneic Hematopoietic Stem Cell Transplantation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-02-10"
protocolSection.identificationModule.nctId: "NCT05674539"
protocolSection.identificationModule.officialTitle: "Reduced Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Randomised, Multi-Center, Phase III Study"
protocolSection.statusModule.overallStatus: "ENROLLING_BY_INVITATION"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.